| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Lexaria Bioscience (NASDAQ:LEXX) just disclosed its Q1 earnings on Friday, January 10, 2025 at 02:19 PM.
Here's a brief overview of the earnings report.
Lexaria Bioscience missed estimated earnings by -33.0%, reporting an EPS of $-0.16 versus an estimate of $-0.12.
Revenue was up $32 thousand from the same period last year.
During the previous quarter, the company missed on EPS by $0.04, leading to a 2.0% drop share price change the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Lexaria Bioscience visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: LEXX
